Willman E A, Collins W P, Clayton S G
Br J Obstet Gynaecol. 1976 May;83(5):337-41. doi: 10.1111/j.1471-0528.1976.tb00839.x.
The concentrations of prostaglandin E2 and F2alpha were measured by radioimmunoassay in samples of endometrial tissue from 155 women. The results showed that the concentration of prostaglandins E2 (ng/100 mg of wet tissue; mean +/- SD) in tissue from apparently healthy women with regular menstrual cycles was 79-3 +/- 9-9 during the menstrual period. The level in the proliferative and early secretory phases fell to 11-8 +/- 4-0 and 13-3 +/- 8-3 respectively. During the late secretory phase there was a significant increase to 20-1 +/- 10-8. The corresponding values from patients with fibromyomata and without menorrhagia were similar. However, the concentration in tissue from patients with fibromyomata and menorrhagia was significantly higher (63-9 +/- 17-9) during the secretory phase of the uterine cycle. In addition, the amount was significantly higher in the groups with dysmenorrhoea (19-0 +/- 4-5 proliferative; 68-0 +/-18-15 secretory) and irregular uterine bleeding (78-3 +/- 59-0 proliferative; 87-4 +/- 64-9 secretory). The mean concentration was higher in cases of endometriosis, and significantly elevated in endometrial carcinoma. The results for prostaglandin F2alpha showed a similar pattern, but the changes were less marked in patients with irregular dysfunctional bleeding. The findings are discussed.
采用放射免疫分析法测定了155名女性子宫内膜组织样本中前列腺素E2和F2α的浓度。结果显示,月经周期正常的明显健康女性在月经期,其组织中前列腺素E2的浓度(每100毫克湿组织中的纳克数;均值±标准差)为79.3±9.9。增殖期和分泌早期的水平分别降至11.8±4.0和13.3±8.3。在分泌晚期显著升高至20.1±10.8。患有子宫肌瘤且无月经过多的患者的相应值相似。然而,患有子宫肌瘤且月经过多的患者在月经周期分泌期的组织浓度显著更高(63.9±17.9)。此外,痛经组(增殖期19.0±4.5;分泌期68.0±18.15)和子宫不规则出血组(增殖期78.3±59.0;分泌期87.4±64.9)的含量也显著更高。子宫内膜异位症患者的平均浓度更高,子宫内膜癌患者则显著升高。前列腺素F2α的结果显示出类似的模式,但在功能失调性子宫出血不规则的患者中变化不太明显。对这些发现进行了讨论。